Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 51 min ago
Peer-reviewedCC BY-NC-NDTranslational andrology and urology

Sodium-glucose cotransporter 2 inhibitors vs. glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors for incident and recurrent urolithiasis: a European Association of Urology Endourology systematic review

  • Arianna Pischetola1
  • Francesco Esperto1
  • Arman Tsaturyan2
  • Ali Talyshinski3
  • Selcuk Guven4
  • Abhishek Singh5
  • Bhaskar Kumar Somani6
6 affiliations
  1. 1Department of Urology , Fondazione Policlinico Campus Bio-Medico of Rome , Rome , ;
  2. 2Department of Urology , Yerevan State Medical University , Yerevan , ;
  3. 3Genome Clinic , Astana , ;
  4. 4Department of Urology , Necmettin Erbakan University , School of Medicine , Konya , ;
  5. 5Muljibhai Patel Urological Hospital , Nadiad , ;
  6. 6Department of Urology , University Hospital Southampton , Southampton ,
Read full textPDFCite

Related

  1. Association of Glucagon-like Peptide-1 Receptor Agonists Versus Dipeptidyl Peptidase-4 Inhibitors with Tuberculosis and Mortality in Adults with Diabetes
    Chun-Hsiang Hsu, Renin Chang, Chiu-Fan Chen +5
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textEndocrinology & metabolismCrossrefEurope PMC
  2. Association between chronic sodium-glucose cotransporter 2 inhibitors use and right ventricular function in hemodynamically stable patients with acute pulmonary embolism
    Gassan Moady, Shir Maman, Robert Dragu +2
    Frontiers in Cardiovascular MedicinePeer-reviewedCC BY 4.0Full textCardiovascular medicineCrossrefDOAJ
  3. Plant-Derived Dipeptidyl Peptidase-4 Inhibitors in Cardiometabolic Disorders: A Critical Review of Natural Scaffolds and Experimental Evidence
    Kuanysh Zhapar, Diana Samatkyzy, Diana Valishayeva +3
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Sodium-Glucose Cotransporter 2 Inhibitors: A Scoping Review of Current Evidence, Mechanisms, and Adverse Effects
    Journal of Brown hospital medicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  5. Gene‐Guided Therapy in Type 2 Diabetes Mellitus: An Integrative Review of the Pharmacogenetics of Metformin and Sodium‐Glucose Cotransporter‐2 Inhibitors
    Imran Hossain, Mahnoor Haidar, Mahfuj Ahmed Ratul +4
    Endocrinology, diabetes & metabolismPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC

Cite

BibTeXRIS
BibTeX
@article{pischetola2026sodiumglucose,
  title = {{Sodium-glucose cotransporter 2 inhibitors vs. glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors for incident and recurrent urolithiasis: a European Association of Urology Endourology systematic review}},
  author = {Arianna Pischetola and Francesco Esperto and Arman Tsaturyan and Ali Talyshinski and Selcuk Guven and Abhishek Singh and Bhaskar Kumar Somani},
  journal = {Translational andrology and urology},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13657777},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Sodium-glucose cotransporter 2 inhibitors vs. glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors for incident and recurrent urolithiasis: a European Association of Urology Endourology systematic review
AU  - Arianna Pischetola
AU  - Francesco Esperto
AU  - Arman Tsaturyan
AU  - Ali Talyshinski
AU  - Selcuk Guven
AU  - Abhishek Singh
AU  - Bhaskar Kumar Somani
PY  - 2026
DA  - 2026/09/23
JO  - Translational andrology and urology
UR  - https://europepmc.org/article/PMC/PMC13657777
SN  - 2223-4691
ER  -